SCHEMBL5698663

SCHEMBL5698663

CS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)c3c2-c2ccc(F)cc2CS3)cc1

nearest known ligand 0.82

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 18/20 0.82
PTGS1 P23219 10/20 0.82
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
GRIA2 P42262 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8933877 0.90 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8471848 0.90 PTGS2 (0.84) PTGS2PTGS1CYP1A2CYP2D6GRIA2
SCHEMBL8933971 0.81 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8933916 0.80 PTGS2 (1.00) PTGS2PTGS1CYP1A2CYP2D6GRIA2
SCHEMBL8933921 0.80 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8933906 0.79 PTGS2 (0.80) PTGS2PTGS1
SCHEMBL8933893 0.76 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8934224 0.76 PTGS2 (0.84) PTGS2PTGS1CYP1A2CYP2D6GRIA2
SCHEMBL8933829 0.74 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8933896 0.74 PTGS2 (0.72) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed
WO-1996009304-A1 BENZOPYRANOPYRAZOLYL DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-28 WO disclosed